article thumbnail

Sanofi extends Health2Sync digital diabetes partnership to Japan

pharmaphorum

Digital health company Health2Sync will work with Sanofi on digitising its range of insulin products in Japan, extending an earlier alliance in other markets. The new Japanese alliance will however go a step further. “Patients are receiving an average of 14.8 “Patients are receiving an average of 14.8

Insulin 52
article thumbnail

The Longevity Breakthrough Your Doctor Won't Tell You About

The Pharma Data

Product Name: The Longevity Breakthrough Your Doctor Won't Tell You About. The Longevity Breakthrough Your Doctor Won't Tell You About is backed with a 60 Day No Questions Asked Money Back Guarantee. One French scientists concluded that this ingredient contains something which stimulates the growth of cancerous tumors!

Doctors 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Our Product – Blood Sugar Code

The Pharma Data

Product Name: Our Product – Blood Sugar Code. Click here to get Our Product – Blood Sugar Code at discounted price while it’s still available… All orders are protected by SSL encryption – the highest industry standard for online security from trusted vendors. Any likeness to a real Daniel C.

article thumbnail

Enabling the next wave of innovative drug therapies with speciality enzymes

Pharmaceutical Technology

For hundreds of years, we have found myriad uses for microbial enzymes in manufacturing – from food, drink, and household products to a range of industrial applications. Continuing advancements within this field deliver new hope to doctors and patients, transforming disease outcomes for previously incurable indications.

Drugs 295
article thumbnail

The US biosimilar market: Predictions for 2021

pharmaphorum

As we’ve seen over those five years, biosimilars are critical in continuing to provide doctors and patients choice in their care plans as well as continuing to decrease overall healthcare costs. One of these markets is the insulin market. Americans pay ten times as much for insulin as Canadian patients do.

Marketing 118
article thumbnail

Medtronic Introduces New Minimed 770G For Type 1 Diabetes

XTalks

This is an insulin pump system that offers the company’s most advanced SmartGuard technology. Furthermore, the notices can also be automatically shared with clinicians and educators to help facilitate more effective telehealth visits and product trainings. ” The pancreas of people with type 1 diabetes cannot produce insulin.

Insulin 98
article thumbnail

Health2Sync and Sanofi to digitally manage diabetes in Taiwan

pharmaphorum

While Sanofi is winding up its R&D operations in diabetes it is turning to digital solutions to get the most from its established products for the disease. But use of insulin is relatively low compared with American and European countries and there are an estimated 2.2 million diabetes patients in Taiwan.

Insulin 75